Sean David to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Sean David has written about Randomized Controlled Trials as Topic.
Connection Strength
0.539
-
Retrospective analysis of changing characteristics of treatment-seeking smokers: implications for further reducing smoking prevalence. BMJ Open. 2016 06 29; 6(6):e010960.
Score: 0.101
-
Opioid antagonists for smoking cessation. Cochrane Database Syst Rev. 2013 Jun 06; (6):CD003086.
Score: 0.082
-
Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials. Nicotine Tob Res. 2011 Mar; 13(3):157-67.
Score: 0.069
-
Smoking cessation in primary care. BMJ. 2008 May 31; 336(7655):1200-1.
Score: 0.057
-
Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials. Nicotine Tob Res. 2007 12; 9(12):1251-7.
Score: 0.056
-
Do medications increase the efficacy of digital interventions for smoking cessation? Secondary results from the iCanQuit randomized trial. Addiction. 2024 04; 119(4):664-676.
Score: 0.042
-
Should we prescribe antibiotics for acute conjunctivitis? Am Fam Physician. 2002 Nov 01; 66(9):1649-50.
Score: 0.039
-
Should we use multiple risk factor interventions for the primary prevention of coronary heart disease? Am Fam Physician. 2002 Jul 15; 66(2):245-6.
Score: 0.038
-
Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers. Cochrane Database Syst Rev. 2017 09 08; 9:CD011823.
Score: 0.027
-
Association of the DRD2 gene Taq1A polymorphism and smoking behavior: a meta-analysis and new data. Nicotine Tob Res. 2009 Jan; 11(1):64-76.
Score: 0.015
-
Are there sex differences in transdermal nicotine replacement therapy patch efficacy? A meta-analysis. Nicotine Tob Res. 2004 Oct; 6(5):769-76.
Score: 0.011